# AVITA Medical (RCEL) — Analyst Forecast

RCEL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rcel/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 5 | 0 | 1 | 6 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $12.00 | $13.67 | $15.00 | 3 |

Last price $13.41 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | BTIG | Maintained | Buy | $15.00 |
| Aug 28, 2026 | Lake Street | Maintained | Buy | $12.00 |
| Aug 19, 2026 | BTIG | Maintained | Buy | $11.00 |
| Aug 19, 2026 | TD Cowen | Maintained | Buy | $14.00 |
| Aug 7, 2026 | BTIG | Upgraded | Neutral → Buy | $7.00 |
| May 15, 2026 | Lake Street | Upgraded | Hold → Buy | $6.00 |
| Apr 9, 2026 | D. Boral Capital | Maintained | Buy | $10.00 |
| Apr 8, 2026 | D. Boral Capital | Maintained | Buy | $10.00 |
| Mar 5, 2026 | Northland Capital Markets | Initiated Coverage | Outperform | $10.00 |
| Feb 17, 2026 | D. Boral Capital | Maintained | Buy | $10.00 |
| Jan 26, 2026 | D. Boral Capital | Maintained | Buy | $10.00 |
| Jan 16, 2026 | Lake Street | Maintained | Hold | $3.50 |
| Jan 15, 2026 | D. Boral Capital | Maintained | Buy | $10.00 |
| Nov 20, 2025 | BTIG | Upgraded | Sell → Neutral | — |
| Nov 7, 2025 | D. Boral Capital | Maintained | Buy | $14.00 |
| Oct 17, 2025 | D. Boral Capital | Maintained | Buy | $14.00 |
| Oct 17, 2025 | Lake Street | Downgraded | Buy → Hold | $4.00 |
| Sep 15, 2025 | D. Boral Capital | Maintained | Buy | $14.00 |
| Sep 5, 2025 | D. Boral Capital | Maintained | Buy | $14.00 |
| Aug 11, 2025 | Lake Street | Maintained | Buy | $8.00 |

## Frequently Asked Questions

### What is the price target for RCEL stock?

The average 12-month analyst price target for AVITA Medical (RCEL) is $13.67, with a high estimate of $15.00 and a low of $12.00, across 3 analysts.

### Is RCEL a buy, sell, or hold?

Analysts covering AVITA Medical currently average a Buy rating: 5 buy, 0 hold and 1 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for RCEL?

The average price target of $13.67 implies 1.91% upside from the last price of $13.41.

### What is the latest analyst rating on RCEL?

On Oct 12, 2026, BTIG maintained AVITA Medical at Buy with a price target of $15.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).